BioSpace News Archive

Pharm Country

BD to Present at Barclays Global Healthcare Conference

BD, a leading global medical technology company, announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 9:00 am Eastern Time.

March 1, 2023
·
1 min read
Biotech Bay

Dynavax to Present at the Cowen 43rd Annual Health Care Conference

Dynavax Technologies Corporation (Nasdaq: DVAX) today announced that Kelly MacDonald, Chief Financial Officer, will participate in a fireside chat at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, at 2:10 p.m. E.T.

March 1, 2023
·
1 min read
BioMidwest

Paragon 28 to Present at Upcoming March 2023 Investor Conferences

Paragon 28, Inc. announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will be presenting in fireside chats at two upcoming investor conferences.

March 1, 2023
·
1 min read
Biotech Bay

Revolution Medicines Announces Commencement of Public Offering of Common Stock

Revolution Medicines, Inc., a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, announced that it has commenced an underwritten public offering to sell up to $300 million of shares of its common stock.

March 1, 2023
·
3 min read
BioForest

CTI BioPharma to Present at the 43rd Annual Cowen Health Care Conference

CTI BioPharma Corp. (Nasdaq: CTIC) today announced that the management team will present a corporate overview at the 43rd Annual Cowen Health Care Conference on Wednesday, March 8, 2023 at 10:30 a.m. ET (7:30 a.m. PT).

March 1, 2023
·
1 min read
Bio NC

IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023

IQVIA Holdings Inc., announced that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays Global Healthcare Conference in Miami, FL on Wednesday, March 15, 2023 at 9:30 a.m. ET.

March 1, 2023
·
1 min read
Business

Alvotech Reports Financial Results for Full Year 2022 and Provides Business Update

Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for full year 2022 and provided a summary of recent corporate highlights.

March 1, 2023
·
26 min read
Business

Nephros and Donastar Announce Strategic Partnership

Nephros, Inc. announced a new partnership engaging Donastar Enterprises LLC as the exclusive master distributor for Nephros commercial filters in the food & beverage and hospitality markets.

March 1, 2023
·
4 min read
Business

Cellectis to Report Fourth Quarter and Year-End 2022 Financial Results on March 8, 2023

Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS) today announced that it will report financial results for the fourth quarter and year-end 2022 ending December 31st, 2022, on Wednesday, March 8, 2023, after the close of the US market.

March 1, 2023
·
3 min read
Profound Medical to Present at the 43rd Annual Cowen Health Care Conference

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) today announced that its CEO and Chairman, Arun Menawat, will present an update on the Company’s business at the 43rd Annual Cowen Health Care Conference on Wednesday, March 8, 2023 at 9:10 a.m. Eastern Time.

March 1, 2023
·
2 min read